Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 69 (2019): Issue 1 (March 2019)
Open Access
Sesquiterpenes α-humulene and β-caryophyllene oxide enhance the efficacy of 5-fluorouracil and oxaliplatin in colon cancer cells
Martin Ambrož
Martin Ambrož
,
Markéta Šmatová
Markéta Šmatová
,
Michaela Šadibolová
Michaela Šadibolová
,
Eva Pospíšilová
Eva Pospíšilová
,
Pavlína Hadravská
Pavlína Hadravská
,
Michaela Kašparová
Michaela Kašparová
,
Veronika Hanušová Skarková
Veronika Hanušová Skarková
,
Věra Králová
Věra Králová
and
Lenka Skálová
Lenka Skálová
| Dec 07, 2018
Acta Pharmaceutica
Volume 69 (2019): Issue 1 (March 2019)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 07, 2018
Page range:
121 - 128
Accepted:
Jul 17, 2018
DOI:
https://doi.org/10.2478/acph-2019-0003
Keywords
terpenes
,
Caco-2
,
SW-620
,
combination therapy
© 2019 Martin Ambrož et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Martin Ambrož
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Markéta Šmatová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Michaela Šadibolová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Eva Pospíšilová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Pavlína Hadravská
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Michaela Kašparová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Veronika Hanušová Skarková
Department of Medical Biology and Genetics, Charles University in Prague, Faculty of Medicine in Hradec Králové
Hradec Králové
Věra Králová
Department of Medical Biology and Genetics, Charles University in Prague, Faculty of Medicine in Hradec Králové
Hradec Králové
Lenka Skálová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové